International CRO International CRO

Cromos pharma: international CRO

Cromos Pharma: International CRO

Vast US capabilities combined with an in-depth regional expertise in Central and Eastern Europe, Central Asia and Türkiye.

Vast US capabilities combined with an in-depth regional expertise in Central and Eastern Europe, Central Asia and Türkiye.

Learn more
No Patients No Payment No Patients No Payment

No Patients
No Payment

No Patients
No Payment

A unique risk-sharing program
If we don’t recruit –
Sponsor doesn’t pay.

A unique risk-sharing program
If we don’t recruit –
Sponsor doesn’t pay.

Learn more
Free Multicountry Feasibility Report Free Multicountry Feasibility Report

Free Multicountry Feasibility Report

Free Multicountry Feasibility Report

We invite you to take advantage of Cromos Pharma’s Free Multicountry Feasibility Report for your clinical trials.

We invite you to take advantage of Cromos Pharma’s Free Multicountry Feasibility Report for your clinical trials.

Learn more
Deep dive into Clinical Trials Specifics in Türkiye | Cromos Pharma Deep dive into Clinical Trials Specifics in Türkiye | Cromos Pharma

Clinical Trials Specifics in Türkiye

Clinical Trials Specifics in Türkiye

Discover why Türkiye should be considered for the next clinical research venture.

Discover why Türkiye should be considered for the next clinical research venture.

Learn more
Clinical Research Focus 28th Edition May | Cromos Pharma Clinical Research Focus 28th Edition May | Cromos Pharma

Clinical research focus. 28th edition

Clinical research focus. 28th edition

Clinical Research Focus featuring topical articles of interest to the clinical trial community.

Clinical Research Focus featuring topical articles of interest to the clinical trial community.

Learn more
Clinical Trials Day 2024 | Cromos Pharma Clinical Trials Day 2024 | Cromos Pharma

Clinical Trials
Day 2024

Clinical Trials
Day 2024

Celebrating Clinical Trials Day: The Most Unusual and Wonderful Studies Ever Conducted

Celebrating Clinical Trials Day: The Most Unusual and Wonderful Studies Ever Conducted

Learn more
Cromos Pharma: International CRO No Patients
No Payment
 Free Multicountry Feasibility Report Clinical Trials Specifics in Türkiye Clinical research focus. 28th edition Featured Venue
of the Month
Meet Cromos Pharma
ASCO Annual Meeting 2024 | Cromos Pharma
May 31 - June 4, 2024
Chicago, IL
BIO 2024 | Cromos Pharma
June 3-6, 2024
San Diego, CA
Contact us

why cromos pharma

Cromos Pharma is a US based international contract research organization (CRO) delivering integrated clinical research solutions that accelerate drug development.

Icon, clinical trials in central & easter europe
350 clinical trials conducted in 70+ indications
Icon, clinical trials in central & easter europe
120,000+ patients enrolled across 3,500 trial sites
Icon, clinical trials in central & easter europe
20+ operating countries with in-depth local expertise
Learn more

What we do

Icon, clinical trials in central & easter europe
Patient recruitment
Patient recruitment
  • Promotional and educational materials
  • DTC outreach
  • Investigator’s materials
  • Booster visits
  • Referral sites
  • Commitment to patients
  • Patient’s materials
Icon, clinical trials in central & easter europe
Clinical Research Services
Clinical Research Services
  • Capability and Feasibility Assessment
  • Project Management
  • Monitoring Services
Icon, clinical trials in central & easter europe
Regulatory
Services
Regulatory Services
  • Compilation of initial documents for RA and ECs/IRBs
  • Review of IC documentation
  • Obtaining of trial subjects’ insurance
  • Secure import/export licenses
  • Regional regulatory consultation
  • Regulatory strategy and clinical development planning
  • Submissions to Regulatory Agencies
icon - eu legal services
EU legal representation
EU legal representation
  • Your clinical gateway to Europe
  • Legal representation in EU/EEA
  • QP Statement obtainment
  • Cost-effective and time-saving services
Icon, clinical trials in central & easter europe
Medical
Writing
Medical Writing
  • Study concepts and outlines
  • Clinical study protocols and amendments
  • SAP for inclusion into protocol
  • Investigator Brochures
  • Investigational Medicinal Product Dossiers
  • Patient Informed Consent Forms
  • Clinical Study Reports
  • Executive summaries for efficacy or safety, ISS, ISE
  • Reviews of clinical and nonclinical data
  • Patient narratives, SAE narratives
  • Abstracts, posters, and journal articles
Icon, clinical trials in central & easter europe
Biostatistics
and data
management
Data Management
  • CRF development/validation
  • Customized database design/validation
  • Data entry screen design/validation
  • Double data entry
  • Programming under SAS
  • Data validation
  • Data listings
  • Convenient data format for the client
  • Data transfers
  • Data coding
Icon, clinical trials in central & easter europe
CTM
Logitics
CTM Logitics
  • Full Scope of Clinical Trial Logistics Services
  • Controlled access to storage areas
  • 24/7 receipt of IMP and CTM
  • Patented warehouse database program
  • General liability and property insurances
  • Compliance with ISO 9001:2015 & GDP
Icon, clinical trials in central & easter europe
PV
Support
PV Support
  • Therapeutic, technical, and operational excellence
  • Tailored and cost-effective safety solutions
  • Flexible outsourcing of safety functions
  • A team of QPPVs for registered products in EU
  • Updated country-specific regulatory requirements
  • Robust quality system
  • Pharmacovigilance consultancy
Icon, clinical trials in central & easter europe
Independent
Audits
Independent Audits
  • Clinical site GCP audits
  • Documentary Trial Master File audits
  • System Vendor Audits
  • Regulatory Inspection and Sponsor’s audit readiness check

No patients No payment

We are the only CRO that offers a unique risk sharing program, “No Patients – No Payment”, which means that when we don’t recruit, you don’t pay.

Learn more
1. Пилот, разборы, ответы и лайвы

No patients No payment

insights

News

Cromos Pharma's Country Head Speaks at GCP Training Event in Istanbul
Cromos Pharma’s Country Head Speaks at GCP Training Event in Istanbul
We are thrilled to share that Seniz Sagol, Cromos Pharma’s Country Head for Türkiye, represented our team as a speaker at a prominent industry event in Istanbul this week. The one-day GCP Training, accredited by the Ministry of Health, was a collaborative effort alongside Memorial Hospital Group, the Association of Research-Based Pharmaceutical Companies (AIFD), and Uskudar University. This event offered Cromos Pharma an exceptional platform to engage with a broad spectrum of stakeholders...
Read more
Cromos Pharma's Strategic Meeting in Miami
Cromos Pharma’s Strategic Meeting in Miami
Last week, Cromos Pharma US executive team gathered in Miami for a full-day strategy session. This meeting was aimed at reinforcing our collaborative spirit and refining our business approaches. More than just a conventional meeting, it was a great chance for our team members to build stronger bonds and share important ideas We wrapped up the day with a fun team-building activity, which was a great way to end our busy schedule. We also enjoyed some downtime, taking in the beautiful sights of...
Read more
Happy Passover 2024 | Cromos Pharma
Happy Passover 2024
Wishing a joyful Passover to all from Cromos Pharma! May this season bring peace and happiness to your homes. We value the strength and community spirit Passover embodies. Chag...
Read more
Cromos Pharma's Strategic Meeting in Warsaw
Cromos Pharma’s Strategic Meeting in Warsaw
Last week, the Cromos Pharma Poland executive team gathered in Warsaw for a dynamic full-day meeting, marking a significant step in strengthening our internal connections and enhancing operational strategies. This gathering was not just a meeting but an opportunity for team members to forge stronger bonds and share insights. The agenda was packed with constructive discussions aimed at refining our existing processes and exploring potential avenues for expanding our operations within Poland...
Read more
Happy Easter 2024 | Cromos Pharma
Happy Easter 2024
May this Easter bring health, hope, and success to you and your loved ones. Wishing you a joyful celebration from all of us at Cromos...
Read more
FDA approves first direct-to-consumer glucose monitor | Cromos Pharma
Revolutionizing Diabetes Management: FDA Approves First Direct-to-Consumer Glucose Monitor
The FDA has given the green light to the Dexcom Stelo Glucose Biosensor System, the first of its kind continuous glucose monitor (CGM) that will be available directly to consumers. Slated for release in summer 2024, this innovative device offers adults over 18 who do not rely on insulin a novel way to monitor their blood sugar levels. Importantly, the Dexcom Stelo is not recommended for those at risk of severe hypoglycemia as it does not include low blood sugar alerts. In an effort to...
Read more

Events

Meet Vlad Bogin at the ASCO Annual Meeting 2024 | Cromos Pharma
Meet Vlad Bogin at ASCO 2024
The CEO of Cromos Pharma, Vlad Bogin, MD, FACP, is attending the ASCO Conference, scheduled from May 31 to June 4 in Chicago, IL. This prestigious event gathers leading professionals in oncology, and Dr. Bogin is eager to engage with peers, share insights, and explore the latest innovations in cancer treatment and research. To schedule a meeting with Dr. Bogin during the conference or to learn more about our capabilities, please reach out to us at...
Read more
Meet Cromos Pharma at the BIO International Convention 2024
Meet us at the BIO International Convention 2024
Cromos Pharma’s US Business Development Director, Nicole Brenna, is delighted to participate in the BIO International Convention, scheduled for June 3-6, 2024, at the San Diego Convention Center, California. This prestigious event continues to be a highlight, featuring presentations from leading figures in the pharma and biotech sectors. Nicole is eager to share how Cromos Pharma’s extensive expertise in managing all aspects of clinical trials and our innovative solutions can accelerate...
Read more
BioNJ 14th annual BioPartnering Conference | Cromos Pharma
Meet us at the BioNJ BioPartnering Conference 2024
We are delighted to announce that Nicole Brenna, our Director of US Business Development, will be attending the BioNJ’s BioPartnering Conference, which is scheduled for May 14, 2024, in Jersey City, NJ. Nicole looks forward to connecting with potential partners and clients to gain a deeper insight into their clinical development projects. If you are interested in setting up a meeting to discuss your forthcoming clinical trials, please do not hesitate to reach out to us at...
Read more
Meet Vlad Bogin at the Texas Biolife Summit 2024 | Cromos Pharma
Meet Cromos Pharma at the Texas BioLife Summit 2024
We are pleased to announce that Cromos Pharma’s CEO Vlad Bogin, MD, FACP is participating in the Texas BioLife Summit 2024, which is set to take place February 21, 2024 in Dallas, TX. Dr. Bogin will serve as a speaker in the panel discussion titled “Clinical trial development”. The discussion will delve into strategies for selecting optimal trial designs, creating comprehensive clinical trial protocols, and the processes involved in vendor and venue selection. Take this...
Read more
Meet Stephanie Finnegan and Nicole Brenna at SCOPE 2024 | Cromos Pharma
Meet Cromos Pharma at the SCOPE SUMMIT 2024
We are pleased to inform you that Stephanie Finnegan, Chief Operating Officer at Cromos Pharma, and Nicole Brenna, our Director of US Business Development, will be participating in the SCOPE SUMMIT 2024, scheduled from February 11 to 14, 2024, in Orlando, FL. Stephanie and Nicole are enthusiastic about engaging with potential partners and clients to understand their clinical development initiatives better. To schedule a meeting and explore discussions regarding your upcoming clinical trials...
Read more
Meet Cromos Pharma at JP Morgan Conference 2024
Meet Cromos Pharma at 42nd Annual J.P. Morgan Healthcare Conference
We are pleased to announce that Cromos Pharma is once again participating in the JP Morgan Healthcare Conference scheduled for January 8-11, 2024, in San Francisco. Take this opportunity to schedule a meeting with Vlad Bogin, MD, FACP, the CEO of Cromos Pharma, during the event. This is a great chance to discuss your upcoming clinical research plans and learn about the benefits of partnering with us. To arrange a meeting time, please email inquiry@cromospharma.com. Contact us to arrange a...
Read more

Publications

Clinical Trials Day 2024 | Cromos Pharma
Celebrating Clinical Trials Day: Highlighting the Outside-the-Box Studies that Push the Boundaries
May 20th is Clinical Trials Day, a time to honor the vital role clinical research plays in advancing medical science. While this day traditionally highlights the rigorous and essential work behind clinical trials, we thought it would be fun to celebrate in a different way – by showcasing some of the most unconventional, surprising, and unusual clinical studies conducted in recent years. Humans are inherently curious, and this curiosity often leads to some unexpected and unconventional...
Read more
Clinical Research Focus 28th Edition May | Cromos Pharma
Clinical Research Focus. 28th Edition
Anticipating ASCO: Key Trends in Oncology Clinical Research The upcoming ASCO Conference, an essential gathering for oncology professionals, where leading experts will discuss the latest advancements in cancer research and treatment. Cromos Pharma’s CEO, Vlad Bogin, will attend to share his insights. In his new article, Dr. Bogin explores innovative trends and future directions in oncology research.   Please follow the link to learn more. FDA Approves New Antibiotic Zevtera for Serious...
Read more
Clinical Trials in Ukraine 2024 | Cromos Pharma
Ukraine Strives to Remain a Hub for Clinical Trials Despite Conflict
In the last couple of decades Ukraine had established itself as a thriving hub for clinical trials, especially recognized for its advancements in oncology research. Before the conflict began, the country was a beacon for international medical research, attracting increasing number of studies each year. However, the onset of the war significantly slowed this activity, with the number of new trials plummeting from around 300 annually to just 9 in 2022. Resilience Amidst Conflict Two years into...
Read more
Meet Vlad Bogin at the ASCO Annual Meeting 2024 | Cromos Pharma
Anticipating ASCO: Key Trends in Oncology Clinical Research
As we approach the American Society of Clinical Oncology (ASCO) conference, the oncology community is abuzz with anticipation. Recognized as a premier event in the field, ASCO serves as a critical platform for presenting groundbreaking research, discussing innovative treatments, and sharing advancements that shape the future of cancer care. The significance of ASCO is underscored by its role as a catalyst for international collaboration and knowledge exchange. Annually, the conference...
Read more
Rezdiffra Approval | Cromos Pharma
Rezdiffra Approval Sheds Light on the Challenges of NASH Diagnosis and Fibrosis Identification
The recent approval of Rezdiffra (resmetirom), a novel therapeutic for the treatment of non-alcoholic steatohepatitis (NASH) with moderate to advanced liver fibrosis, marks a significant milestone in the fight against this increasingly prevalent liver disease. However, the journey to this point underscores the persistent challenges faced by healthcare professionals in diagnosing NASH and identifying fibrosis levels in affected patients. About the Approval The drug’s safety and efficacy were...
Read more
Clinical Trials in Georgia 2024 | Cromos Pharma
Сlinical Trials in Georgia 2024
Georgia, a country nestled between Eastern Europe and Western Asia, has emerged as a promising destination for clinical trials. With its strategic location and favorable regulatory environment, Georgia has become increasingly attractive to international sponsors seeking to conduct innovative research projects. Since 2013, Cromos Pharma has been at the forefront of managing clinical research in Georgia, establishing a strong presence in Tbilisi, and overseeing a multitude of successful...
Read more

Videos

1. Пилот, разборы, ответы и лайвы
Revolutionizing the landscape for small-cap, development-stage life science companies.
1. Пилот, разборы, ответы и лайвы
Deep dive into Clinical Trials Specifics in Türkiye
1. Пилот, разборы, ответы и лайвы
The Invaluable Role of Explainer Videos
1. Пилот, разборы, ответы и лайвы
Health Awareness Journey with Cromos Pharma | New Year 2024
1. Пилот, разборы, ответы и лайвы
Vlad Bogin will chair the 18th Biopharma Clinical Trials Nexus
1. Пилот, разборы, ответы и лайвы
Cromos Pharma’s Free Multicountry Feasibility Report